Patents by Inventor Martin Wilkins

Martin Wilkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240069628
    Abstract: Augmented reality systems and methods for creating, saving and rendering designs comprising multiple items of virtual content in a three-dimensional (3D) environment of a user. The designs may be saved as a scene, which is built by a user from pre-built sub-components, built components, and/or previously saved scenes. Location information, expressed as a saved scene anchor and position relative to the saved scene anchor for each item of virtual content, may also be saved. Upon opening the scene, the saved scene anchor node may be correlated to a location within the mixed reality environment of the user for whom the scene is opened. The virtual items of the scene may be positioned with the same relationship to that location as they have to the saved scene anchor node. That location may be selected automatically and/or by user input.
    Type: Application
    Filed: September 5, 2023
    Publication date: February 29, 2024
    Applicant: Magic Leap, Inc.
    Inventors: Jonathan Brodsky, Javier Antonio Busto, Martin Wilkins Smith
  • Publication number: 20230357387
    Abstract: The invention relates to ZIP12 antibodies. The invention extends to compositions comprising the antibodies, including pharmaceutical compositions and kits. The invention also extends to methods of making and using the antibodies, for example in therapy and diagnosis of hypoxia-related diseases, such as pulmonary hypertension and cancer.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 9, 2023
    Inventors: Stephanie HOPLEY, Paul HAMBLIN, Martin WILKINS, Lan ZHAO
  • Patent number: 11789524
    Abstract: Augmented reality systems and methods for creating, saving and rendering designs comprising multiple items of virtual content in a three-dimensional (3D) environment of a user. The designs may be saved as a scene, which is built by a user from pre-built sub-components, built components, and/or previously saved scenes. Location information, expressed as a saved scene anchor and position relative to the saved scene anchor for each item of virtual content, may also be saved. Upon opening the scene, the saved scene anchor node may be correlated to a location within the mixed reality environment of the user for whom the scene is opened. The virtual items of the scene may be positioned with the same relationship to that location as they have to the saved scene anchor node. That location may be selected automatically and/or by user input.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: October 17, 2023
    Assignee: Magic Leap, Inc.
    Inventors: Jonathan Brodsky, Javier Antonio Busto, Martin Wilkins Smith
  • Publication number: 20220101607
    Abstract: Augmented reality systems and methods for creating, saving and rendering designs comprising multiple items of virtual content in a three-dimensional (3D) environment of a user. The designs may be saved as a scene, which is built by a user from pre-built sub-components, built components, and/or previously saved scenes. Location information, expressed as a saved scene anchor and position relative to the saved scene anchor for each item of virtual content, may also be saved. Upon opening the scene, the saved scene anchor node may be correlated to a location within the mixed reality environment of the user for whom the scene is opened. The virtual items of the scene may be positioned with the same relationship to that location as they have to the saved scene anchor node. That location may be selected automatically and/or by user input.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Applicant: Magic Leap, Inc.
    Inventors: Jonathan Brodsky, Javier Antonio Busto, Martin Wilkins Smith
  • Patent number: 11248230
    Abstract: The present invention related to identification of therapeutic agents of the treatment, diagnosis, and prevention of pulmonary hypertension.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: February 15, 2022
    Assignee: IP2IPO Innovations Limited
    Inventors: Eduardo Oliver-Perez, Lan Zhao, Martin Wilkins, Tim Aitman
  • Patent number: 11232635
    Abstract: Augmented reality systems and methods for creating, saving and rendering designs comprising multiple items of virtual content in a three-dimensional (3D) environment of a user. The designs may be saved as a scene, which is built by a user from pre-built sub-components, built components, and/or previously saved scenes. Location information, expressed as a saved scene anchor and position relative to the saved scene anchor for each item of virtual content, may also be saved. Upon opening the scene, the saved scene anchor node may be correlated to a location within the mixed reality environment of the user for whom the scene is opened. The virtual items of the scene may be positioned with the same relationship to that location as they have to the saved scene anchor node. That location may be selected automatically and/or by user input.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: January 25, 2022
    Assignee: Magic Leap, Inc.
    Inventors: Jonathan Brodsky, Javier Antonio Busto, Martin Wilkins Smith
  • Publication number: 20200111255
    Abstract: Augmented reality systems and methods for creating, saving and rendering designs comprising multiple items of virtual content in a three-dimensional (3D) environment of a user. The designs may be saved as a scene, which is built by a user from pre-built sub-components, built components, and/or previously saved scenes. Location information, expressed as a saved scene anchor and position relative to the saved scene anchor for each item of virtual content, may also be saved. Upon opening the scene, the saved scene anchor node may be correlated to a location within the mixed reality environment of the user for whom the scene is opened. The virtual items of the scene may be positioned with the same relationship to that location as they have to the saved scene anchor node. That location may be selected automatically and/or by user input.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Applicant: Magic Leap, Inc.
    Inventors: Jonathan Brodsky, Javier Antonio Busto, Martin Wilkins Smith
  • Publication number: 20200017860
    Abstract: The present invention related to identification of therapeutic agents of the treatment, diagnosis, and prevention of pulmonary hypertension.
    Type: Application
    Filed: June 5, 2019
    Publication date: January 16, 2020
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Eduardo Oliver-Perez, Lan Zhao, Martin Wilkins, Tim Aitman
  • Publication number: 20180237784
    Abstract: The present invention relates to identification of therapeutic agents for the treatment, diagnosis, and prevention of pulmonary hypertension.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 23, 2018
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Eduardo OLIVER-PEREZ, Lan ZHAO, Martin WILKINS, Tim AITMAN
  • Publication number: 20140301947
    Abstract: A method for aiding in selecting or adjusting a dose of TSPO imaging or therapeutic agent for use with a subject, the method comprising the step of determining the subject's genotype for TSPO rs6971. A TSPO imaging or therapeutic agent for use in TSPO imaging or therapy in a subject, wherein the subject is a subject whose genotype at TSPO polymorphism position rs6971 is determined. The subject's genotype for TSPO may be taken into account when assessing the results of the TSPO imaging, for example normalising the subject's determined measure of binding of the TSPO agent to take account of the subject's determined genotype. The subject's genotype for TSPO may be taken into account when choosing the TSPO agent and/or the dose of TSPO agent. The subject may be a subject who has been determined to have genotype CC or CT at TSPO polymorphism position rs6971, for example when using a TSPO agent that binds with higher affinity to Aia147TSPO than to Thr147TSPO.
    Type: Application
    Filed: May 31, 2012
    Publication date: October 9, 2014
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: David Owen, Martin Wilkins